USD0.000æéå€ååŒÂ  (ET)
146.35BæäŸ¡ç·é¡
19.50çŽè¿12ã¶æPER
TradingKey æ ªåŒã¹ã³ã¢
å¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
åçäºæž¬
æ ªäŸ¡ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ã®ä¿¡é Œæ
ãªã¹ã¯è©äŸ¡
忥ä»ç€Ÿæ¯èŒ
TradingKey æ ªåŒã¹ã³ã¢
å¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
åçäºæž¬
æ ªäŸ¡ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ã®ä¿¡é Œæ
ãªã¹ã¯è©äŸ¡
忥ä»ç€Ÿæ¯èŒ
TradingKeyã®Pfizer Incã®æ ªåŒã¹ã³ã¢
é貚: USD æŽæ°æå»: 2026-05-08 äž»èŠã€ã³ãµã€ã
Pfizer Incã®ãã¡ã³ãã¡ã³ã¿ã«ãºã¯æ¯èŒçå®å®ã§ããæ¥çããªãŒãããESGé瀺ãšãšãã«ãæé·ã®å¯èœæ§ã¯é«ãã§ããããªã¥ãšãŒã·ã§ã³ã¯é©æ£äŸ¡æ Œãšè©äŸ¡ãããŠããŸããå»è¬åæ¥çã§ã®é äœã¯156äž58äœã§ããæ©é¢æè³å®¶ä¿æçã¯éåžžã«é«ãã§ããéå»1ãæéã«è€æ°ã®ã¢ããªã¹ããããŒã«ããšè©äŸ¡ããæé«ç®æšæ ªäŸ¡ã¯28.88ãšãããŠããŸããäžæçã«ã¯ãæ ªäŸ¡ã¯å®å®æšç§»ãšäºæ³ãããŸããæ ªåŒåžå Žã§ã®ããã©ãŒãã³ã¹ã¯ãã®1ãæã§äœèª¿ã§ããããå瀟ã®ãã¡ã³ãã¡ã³ã¿ã«ãºãšãã¯ãã«ã«ã¯å
調ã§ããæ ªäŸ¡ã¯æ¯æç·ã𿵿ç·ã®éã§æšªã°ãæšç§»ããŠãããã¬ã³ãžçžå Žã§ã®ã¹ã€ã³ã°ãã¬ãŒãã«é©ããŠããŸãã
Pfizer Incã®ã¹ã³ã¢î°î°
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
éåžžã«äœã
éåžžã«é«ã
Pfizer Incã®æ³šç®ãã€ã³ã
匷ã¿ãªã¹ã¯
å
責äºé
ïŒã¢ããªã¹ãã®ã¬ãŒãã£ã³ã°ããã³ç®æšæ ªäŸ¡ã¯ãæ
å ±æäŸã®ã¿ãç®çãšããŠLSEG Data & AnalyticsãæäŸãããã®ã§ãããæè³å©èšãæ§æãããã®ã§ã¯ãããŸããã
財åå¥å
šæ§
é貚: USD æŽæ°æå»: 2026-05-08 Pfizer Incã®çŸåšã®è²¡åã¹ã³ã¢ã¯7.71ã§ãå»è¬åæ¥çã«ãããã©ã³ãã³ã°ã¯156瀟äž92äœã§ãã ãã®è²¡åç¶æ³ã¯åŒ±ãã§ãã ãŸããäºæ¥å¹çã¯é«ãã§ãã ææ°ååæã®å£²äžé«ã¯14.45Bã§ãåå¹Žåææ¯å¢å ã®5.37%ã§ãããäžæ¹ãçŽå©çã¯åå¹Žåææ¯å¢å ã®9.44%ãšãªããŸããã
é¢é£èšäº
çŸéããã³çŸéåçç©
ç·è³ç£
è² åµåèš
ããªãŒãã£ãã·ã¥ãããŒ

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
é¢é£èšäº
ç·å£²äžé«
å¶æ¥å©ç
ç·è³ç£
販売費 & äžè¬ç®¡çè²»

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
é¢é£èšäº
å¶æ¥æŽ»åã«ãããã£ãã·ã¥ãããŒ
çšåŒåŸå©ç

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
é¢é£èšäº
å¶æ¥æŽ»åã«ãããã£ãã·ã¥ãããŒ
ç·å£²äžé«

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
é¢é£èšäº
ããªãŒãã£ãã·ã¥ãããŒ

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
Pfizer Incã®äŒæ¥äŸ¡å€è©äŸ¡
é貚: USD æŽæ°æå»: 2026-05-08Pfizer Incã®çŸåšã®ããªã¥ãšãŒã·ã§ã³ã¹ã³ã¢ã¯8.49ã§ãå»è¬åæ¥çã§ã¯156瀟äž17äœã§ãã çŸåšã®PERã¯19.50ã§ãçŽè¿é«å€79.17ã305.96%äžåããçŽè¿å®å€-513.09ã2730.85%äžåã£ãŠããŸãã
ããªã¥ãšãŒã·ã§ã³
PER
PBRïŒæ ªäŸ¡çŽè³ç£åçïŒ
PSR
PCFR
æ¥çå
é äœ 58/156

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
åçäºæž¬
é貚: USD æŽæ°æå»: 2026-05-08Pfizer Incã®çŸåšã®åçäºæž¬ã¹ã³ã¢ã¯6.84ã§ãå»è¬åæ¥çã§ã¯156瀟äž127äœã§ãã ç®æšæ ªäŸ¡ã®å¹³åã¯29.00ã§ãæé«ã¯37.54ãæäœã¯24.00ã§ãã
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
財åäºæž¬

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
å
責äºé
ïŒã¢ããªã¹ãã®ã¬ãŒãã£ã³ã°ããã³ç®æšæ ªäŸ¡ã¯ãæ
å ±æäŸã®ã¿ãç®çãšããŠLSEG Data & AnalyticsãæäŸãããã®ã§ãããæè³å©èšãæ§æãããã®ã§ã¯ãããŸããã
æ ªäŸ¡ã¢ã¡ã³ã¿ã
é貚: USD æŽæ°æå»: 2026-05-08Pfizer Incã®çŸåšã®äŸ¡æ Œã¢ã¡ã³ã¿ã ã¹ã³ã¢ã¯6.39ã§ãå»è¬åæ¥çã§ã¯156瀟äž120äœã§ãã çŸåšãæ ªäŸ¡ã¯æµæç·27.15ãšæ¯æç·24.91ã®éã§æšç§»ããŠãããã¬ã³ãžçžå Žã§ã®ã¹ã€ã³ã°ãã¬ãŒãã«é©ããŠããŸãã
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
ææš
î°
î°
æ¬ææšæ©èœã¯ãåçš®ãã¯ãã«ã«ææšãçšããŠéèååã®æ°å€åæãšæ¹åæ§è©äŸ¡ãæäŸããæè¡çãªèŠçŽã衚瀺ããŸãã
æ¬æ©èœã§ã¯MACDã»RSIã»KDJã»StochRSIã»ATRã»CCIã»WRã»TRIXã»MAã®9çš®é¡ã®äž»èŠãã¯ãã«ã«ææšãç¶²çŸ
ããŠããŸããæé軞ã¯ãèªèº«ã®ããŒãºã«åãããŠèª¿æŽå¯èœã§ãã
ãã¯ãã«ã«åæã¯æè³å€æã®äžèŠçŽ ã«éãããæ°å€ã«ããæ¹åæ§è©äŸ¡ã«çµ¶å¯Ÿçãªåºæºã¯ãããŸãããè¡šç€ºçµæã¯ãããŸã§åèæ
å ±ã§ãããææšèšç®ã»èŠçŽã®æ£ç¢ºæ§ã«ã€ããŠåœæ¹ã¯è²¬ä»»ãè² ããããŸãã
ææš
売ã(4)
äžç«(2)
è²·ã(0)
ç§»åå¹³å
売ã(6)
äžç«(0)
è²·ã(0)
æ©é¢æè³å®¶ã®ä¿¡é Œæ
é貚: USD æŽæ°æå»: 2026-05-08Pfizer Incã®çŸåšã®æ©é¢æè³å®¶ææ ªã¹ã³ã¢ã¯5.00ã§ãå»è¬åæ¥çã§ã¯156瀟äž71äœã§ãã ææ°ã®æ©é¢æè³å®¶ä¿ææ¯çã¯69.87%ã§ãåååææ¯å¢å 3.03%ã§ãã æå€§ã®æ©é¢æè³å®¶ã¯ãã³ã¬ãŒãã§ãåèš515.41Mæ ªïŒçºè¡æžæ ªåŒã®9.04%ïŒãä¿æããŠãããä¿ææ¯çã¯æžå°1.24%ã§ãã
æ©é¢æè³å®¶ä¿ææ ª

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
æ ªäž»åå
State Street Investment Management (US)
BlackRock Institutional Trust Company, N.A.
Geode Capital Management, L.L.C.
Norges Bank Investment Management (NBIM)
State Farm Insurance Companies
BlackRock Asset Management Ireland Limited
MFS Investment Management
ãªã¹ã¯è©äŸ¡î°î°
é貚: USD æŽæ°æå»: 2026-05-08ç±³ãã«ææ°ã¯çŸåšäžç«ã®ç¶æ
ã«ãããå»è¬åã®å
é忥çã«äžç«çãªã®åœ±é¿ãåãŒããŠããŸãããã«ææ°ïŒDXYïŒã¯ããŠãŒããåãè±ãã³ããã«ãããã«ãã¹ãŠã§ãŒãã³ã»ã¯ããŒããã¹ã€ã¹ã»ãã©ã³ãå«ãäž»èŠé貚ãã¹ã±ããã«å¯Ÿããç±³ãã«ã®äŸ¡å€ã枬å®ãããã®ã§ãã Pfizer Incã®çŸåšã®ãªã¹ã¯è©äŸ¡ã¹ã³ã¢ã¯8.92ã§ãå»è¬åæ¥çã§ã¯156瀟äž20äœã§ãã å瀟ã®ããŒã¿å€ã¯0.31ã§ãã ããã¯ãäžæçžå Žã§ã¯æ ªäŸ¡ãåžå Žå
šäœïŒææ°ïŒãäžåãåŸåãããäžæ¹ã§ãäžèœçžå Žã§ã¯äžèœå¹
ãéå®çãšãªãåŸåã瀺ããŠããŸãã Pfizer Incã®ææ°ã®ESGé瀺ã¯å»è¬åæ¥çããªãŒãããŠãããç°å¢ç®¡çã瀟äŒç責任ãã¬ããã³ã¹ã®ååéã§ãã³ã³ãã©ã€ã¢ã³ã¹ãéµå®ããåè¶ããããã©ãŒãã³ã¹ã瀺ããŠããŸããããã¯å
šäœçãªãªã¹ã¯ã®è»œæžã«å¯äžããå¯èœæ§ããããŸãã
S&P 500ææ°ãšã®ããŒã¿å€
0.31
240æ¥éã®æå€§ãããŒããŠã³
+11.47%
240æ¥éã®ãã©ãã£ãªãã£
+23.66%
æ»ã
æ¥æ¬¡ãªã¿ãŒã³ïŒæå€§ïŒ
æ¥æ¬¡ãªã¿ãŒã³ïŒæå°ïŒ
ãªã¹ã¯è©äŸ¡
ãªã¿ãŒã³/ãããŒããŠã³æ¯ç
ãã©ãã£ãªãã£
å®çŸãã©ãã£ãªãã£
æšæºåãã¥ã«ãŒã¬ã³ãž
ããŠã³ãµã€ããªã¹ã¯èª¿æŽåŸãªã¿ãŒã³
æå€§æ¥æ¬¡äžæãã©ãã£ãªãã£
æå€§æ¥æ¬¡äžèœãã©ãã£ãªãã£
æµåæ§
売買å転çã®å€åå¹
財åå¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
åçäºæž¬
æ ªäŸ¡ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ã®ä¿¡é Œæ
ãªã¹ã¯è©äŸ¡

Catalyst Pharmaceuticals Inc
CPRX
財åå¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
åçäºæž¬
æ ªäŸ¡ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ã®ä¿¡é Œæ
ãªã¹ã¯è©äŸ¡

Jazz Pharmaceuticals PLC
JAZZ
財åå¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
åçäºæž¬
æ ªäŸ¡ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ã®ä¿¡é Œæ
ãªã¹ã¯è©äŸ¡

Collegium Pharmaceutical Inc
COLL
財åå¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
åçäºæž¬
æ ªäŸ¡ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ã®ä¿¡é Œæ
ãªã¹ã¯è©äŸ¡

Kiniksa Pharmaceuticals International PLC
KNSA
財åå¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
åçäºæž¬
æ ªäŸ¡ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ã®ä¿¡é Œæ
ãªã¹ã¯è©äŸ¡

Neurocrine Biosciences Inc
NBIX
財åå¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
åçäºæž¬
æ ªäŸ¡ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ã®ä¿¡é Œæ
ãªã¹ã¯è©äŸ¡
詳现ãèŠã